The bill establishes the Kidney Disease Study Commission within the New Jersey Department of Health, consisting of nine members, including three ex officio members (the Commissioner of Health, the Commissioner of Human Services, and the Director of the Office of Minority and Multicultural Health) and six public members with expertise in kidney disease research or treatment. The public members will be appointed by various legislative leaders and the Governor, with terms ranging from one to three years. The commission will operate without compensation for its members, who will be reimbursed for necessary expenses, and will be supported by administrative staff from the Department of Health.

The commission's primary responsibility is to promote research on various aspects of kidney disease, particularly focusing on the causes and complications of kidney disease in minority populations and underserved communities. This includes investigating socioeconomic, geographic, and clinical factors that contribute to increased rates of kidney disease and lower rates of kidney transplants in these populations. The commission is also tasked with submitting an annual report to the Governor and the Legislature by January 30, detailing its activities, research findings, and recommendations for future initiatives related to kidney disease.